Nathan Chadwick Davis, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 114 Gateway Corporate Blvd Ste 230, Columbia, SC 29203 Phone: 843-792-6200 |
Karl A Lozanne, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1910 Blanding St, Columbia, SC 29201 Phone: 803-256-4107 |
Kimberly Sue Bregenzer, FNP Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Richland Medical Park Dr Ste 310, Columbia, SC 29203 Phone: 803-434-8323 Fax: 803-434-8326 |
Bertram Richter, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Richland Medical Park Dr Ste 310, Columbia, SC 29203 Phone: 803-434-8323 Fax: 803-434-8326 |
Roham Moftakhar, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Richland Medical Park Dr, Suite 310, Columbia, SC 29203 Phone: 803-434-8323 Fax: 803-434-8326 |
Dr. Erwin Zeta Mangubat, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Richland Medical Park Dr, Suite 310, Columbia, SC 29203 Phone: 803-434-8323 Fax: 803-434-8326 |
Dr. Seth Shawn Molloy, D.O., M.S. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1910 Blanding St, Columbia, SC 29201 Phone: 803-256-4107 Fax: 803-254-2825 |
Dr. Stanley O Skarli, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Richland Medical Park Dr, Columbia, SC 29203 Phone: 803-434-8323 Fax: 803-434-8326 |
David Calvin Straus, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Richland Medical Park Dr Ste 310, Columbia, SC 29203 Phone: 803-434-8323 Fax: 803-434-8326 |
Devanand Anthony Dominique, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Richland Medical Park Dr Ste 310, Columbia, SC 29203 Phone: 803-434-8323 Fax: 803-434-8326 |
Dr. Burke Hood Dial, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3 Richland Medical Park Rd, Suite 310, Columbia, SC 29203 Phone: 803-434-8323 Fax: 803-434-8326 |
William M Rambo Jr., M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1910 Blanding St, Columbia, SC 29201 Phone: 803-256-4107 |
Thomas J Holbrook, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 14 Richland Medical Park Dr Ste 350, Columbia, SC 29203 Phone: 803-434-1663 Fax: 803-434-3894 |
Thomas J Holbrook Jr., M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1910 Blanding St, Columbia, SC 29201 Phone: 803-256-4107 |
Raymond Charles Sweet, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3 Richland Medical Park Dr, Suite 310, Columbia, SC 29203 Phone: 803-434-8323 Fax: 803-434-8326 |
Randall G Drye, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1910 Blanding St, Columbia, SC 29201 Phone: 803-256-4107 |
News Archive
In a study published in the journal PNAS scientists of the German Center for Neurodegenerative Diseases present new findings on the role of the protein Tau in certain brain diseases.
HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.
Neurodegenerative disorders such as Alzheimer's disease are typically characterized by protein deposits in the brain. These are comprised of defective, insoluble proteins which no longer fulfill their function and which cells are unable to break down. The work group headed by Professor Christian Behl of the Institute of Pathobiochemistry of the University Medical Center of Johannes Gutenberg University Mainz has determined the RAB3GAP complex as a novel factor that influences the efficient degradation of proteins.
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the United States Food and Drug Administration informed CTI that due to severe weather conditions in the Washington, D.C. area, the FDA is postponing the Oncologic Drugs Advisory Committee ("ODAC") meeting that was to be held on Wednesday, February 10, 2010 to discuss the pixantrone New Drug Application ("NDA"). The FDA indicated that it intends to reschedule the meeting as soon as the FDA can determine a schedule that will allow them to reconvene the advisory panel.
› Verified 8 days ago